Clinical Trials › NCT06261489
Active, Not RecruitingPhase 2
Cannabis (THC vs. CBD) in Multiple Sclerosis
Sponsored by University of Calgary
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 30
Target enrollment
Dec 2025
Start date
Sep 2026
Expected completion
Interventions / Treatments
THCCBD
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
